Larry Robbins Exits CVS Health Board

Dow Jones

08/18

Larry Robbins, CEO of Glenview Capital, departed the CVS Health board after joining in 2024. Robbins served on the Audit and Public Policy and External Affairs Committees during a period of transition for the company. His arrival came with a proposal to refresh corporate governance, improve operating performance, and restore financial discipline, he said. CEO David Joyner said Robbins helped sharpen the company's financial and operational focus and was instrumental in laying the foundation for future success.

This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2660325834"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2660325834\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2660325834?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 04:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2660325834","market":"fut","top_or_hot":-1,"title":"Larry Robbins Exits CVS Health Board","media":"Dow Jones","content":"<html><head></head><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Larry Robbins, CEO of Glenview Capital, departed the CVS Health board after joining in 2024. Robbins served on the Audit and Public Policy and External Affairs Committees during a period of transition for the company. His arrival came with a proposal to refresh corporate governance, improve operating performance, and restore financial discipline, he said. CEO David Joyner said Robbins helped sharpen the company&#39;s financial and operational focus and was instrumental in laying the foundation for future success. \n</p>\n<pre style=\"white-space: pre\"> \n</pre>\n<p>\n     This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. \n</p>\n<pre style=\"white-space: pre\"> \n</pre>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Larry Robbins Exits CVS Health Board</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLarry Robbins Exits CVS Health Board\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-08-18 04:24</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><head></head><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Larry Robbins, CEO of Glenview Capital, departed the CVS Health board after joining in 2024. Robbins served on the Audit and Public Policy and External Affairs Committees during a period of transition for the company. His arrival came with a proposal to refresh corporate governance, improve operating performance, and restore financial discipline, he said. CEO David Joyner said Robbins helped sharpen the company&#39;s financial and operational focus and was instrumental in laying the foundation for future success. \n</p>\n<pre style=\"white-space: pre\"> \n</pre>\n<p>\n     This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. \n</p>\n<pre style=\"white-space: pre\"> \n</pre>\n</font></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1059921491.USD","symbol_name":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2660325834","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2660325834","pubTimestamp":1786998240,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Larry Robbins, CEO of Glenview Capital, departed the CVS Health board after joining in 2024. Robbins served on the Audit and Public Policy and External Affairs Committees during a period of transition for the company. His arrival came with a proposal to refresh corporate governance, improve operating performance, and restore financial discipline, he said. CEO David Joyner said Robbins helped sharpen the company's financial and operational focus and was instrumental in laying the foundation for future success.This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","BK4503":"景林资产持仓","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU1923622614.USD":"Natixis Thematics Meta R/A USD","IHF":"iShares Dow Jones U.S. Health Ca","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4504":"桥水持仓","LU0859254822.USD":"T ROWE PRICE GLOBAL VALUE EQUITY \"A\" (USD) ACC","CVS":"西维斯健康","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU2357627491.SGD":"TRP GLOBAL VALUE EQUITY \"AH\" (SGDHDG) ACC","BK4588":"碎股","BK4550":"红杉资本持仓","RTH":"零售指数ETF-HOLDRs","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BK4552":"Archegos爆仓风波概念","GOTU":"高途","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4506":"内地教育股","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","BK4196":"保健护理服务","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK4510":"在线教育","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","BK4581":"高盛持仓","BK4204":"教育服务","BK4531":"中概回港概念","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BK4585":"ETF&股票定投概念","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC"},"translate_title":"拉里·罗宾斯退出 CVS 健康委员会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVS":1.5,"IHF":0.6,"RTH":0.6,"GOTU":1.5},"content_text":"Larry Robbins, CEO of Glenview Capital, departed the CVS Health board after joining in 2024. Robbins served on the Audit and Public Policy and External Affairs Committees during a period of transition for the company. His arrival came with a proposal to refresh corporate governance, improve operating performance, and restore financial discipline, he said. CEO David Joyner said Robbins helped sharpen the company's financial and operational focus and was instrumental in laying the foundation for future success. \n\n \n\n\n     This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}